The Worldwide Motion Sickness Treatment Market is Projected to reach USD 481 Million by 2029, at a CAGR of 3.2%

Published Date: 26-May-2023

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Motion Sickness Treatment Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Motion Sickness Treatment Market size is expected to reach $481 Million by 2029, rising at a market growth of 3.2% CAGR during the forecast period.

The Anticholinergics market is estimated to grow at a CAGR of 3.6% during (2023 - 2029). This is due to the fact that anticholinergics are drugs that block the neurotransmitter acetylcholine in the central and peripheral nervous systems. The growth in anticholinergic drugs is due to their advantages and effectiveness in preventing motion sickness. Although various treatments are available for motion sickness, including over-the-counter medications and prescription drugs, anticholinergics, particularly scopolamine transdermal patches, are highly efficacious.

The Oral market is leading the Global Motion Sickness Treatment Market by Route of Administration in 2022; thereby, achieving a market value of $344.4 Million by 2029. The growth is attributed to the diverse range of products offered in this segment by the major players. The high demand for antihistaminic medications is primarily met through tablet, capsule, and pill dosage forms. Also, prominent industry leaders are providing a diverse selection of oral medications for motion sickness that offer a more economical alternative to other treatment options, contributing to the segment's growth.

The Online Pharmacies market is anticipated to grow at a CAGR of 4.2% during (2023 - 2029). This is due to the quick accessibility, time-saving benefits, and significant discounts and incentives offered by online providers. Additionally, there has been a significant increase in online services, and the realm of electronic commerce is becoming dominant. Online pharmacies offer prescription and over-the-counter medications at competitive prices compared to traditional pharmacies.

The North America market dominated the Global Motion Sickness Treatment Market by Region in 2022; thereby, achieving a market value of $179.4 Million by 2029. The Asia Pacific market is poised to grow at a CAGR of 3.9% during (2023 - 2029). Additionally, The Europe market would experience a CAGR of 3% during (2023 - 2029).

Full Report:

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country-wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Viatris, Inc., Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Baxter International, Inc., Novartis AG, Abbott Laboratories, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd., Prestige Consumer Healthcare, Inc., WellSpring Pharmaceutical Corporation (Avista Capital Partners).

Global Motion Sickness Treatment Market Segmentation

By Drug Class

  • Antihistamines
  • Anticholinergics
  • Others

By Route of Administration

  • Oral
  • Others

By Distribution Channel

  • Drug Store & Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Viatris, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Amneal Pharmaceuticals, Inc.
  • Baxter International, Inc.
  • Novartis AG
  • Abbott Laboratories
  • Sun Pharmaceutical Industries Ltd.
  • Zydus Lifesciences Ltd.
  • Prestige Consumer Healthcare, Inc.
  • WellSpring Pharmaceutical Corporation (Avista Capital Partners)

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

North America Motion Sickness Treatment Market size & Opportunities 2023-2029

Europe Motion Sickness Treatment Market & Growth Forecast 2023-2029

Asia Pacific Motion Sickness Treatment Market Share & Industry Outlook to 2029

LAMEA Motion Sickness Treatment Market Growth, Trends & Forecasts 2023-2029

Request a Free Sample Copy

Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.